Literature DB >> 6168644

Purification of reverse transcriptase from avian retroviruses using affinity chromatography on heparin-sepharose.

M Golomb, A C Vora, D P Grandgenett.   

Abstract

Reverse transcriptase from Rous sarcoma virus and avian myeloblastosis virus was purified by a rapid two-step procedure using chromatography on phosphocellulose and heparin-Sepharose. The resulting enzyme was homogeneous, had a high specific activity and was free of contaminating nucleases. This procedure has been adapted to small-scale preparation of enzyme from mutant virus containing thermolabile reverse transcriptase, and is equally suitable for large-scale enzyme purification.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6168644     DOI: 10.1016/0166-0934(80)90012-9

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Virus-coded DNA endonuclease from avian retrovirus.

Authors:  M Golomb; D P Grandgenett; W Mason
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

2.  Reverse transcriptase from simian foamy virus serotype 1: purification and characterization.

Authors:  A B Benzair; A Rhodes-Feuillette; R Emanoïl-Ravicovitch; J Peries
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

3.  Avian retrovirus pp32 DNA-binding protein. I. Recognition of specific sequences on retrovirus DNA terminal repeats.

Authors:  T K Misra; D P Grandgenett; J T Parsons
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

4.  Inhibition of human immunodeficiency virus gene amplification by heparin.

Authors:  M Holodniy; S Kim; D Katzenstein; M Konrad; E Groves; T C Merigan
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

5.  Analyses of interactions between heparin and the apical surface proteins of Plasmodium falciparum.

Authors:  Kyousuke Kobayashi; Ryo Takano; Hitoshi Takemae; Tatsuki Sugi; Akiko Ishiwa; Haiyan Gong; Frances C Recuenco; Tatsuya Iwanaga; Taisuke Horimoto; Hiroomi Akashi; Kentaro Kato
Journal:  Sci Rep       Date:  2013-11-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.